Home » Newsletters » BioWorld

BioWorld

Sep. 29, 1999

View Archived Issues

Other News To Note

Nanogen Could Get Another $12M In Aventis Collaboration

Orquest, Biopharm Sign $25M Deal With Sulzer In Bone Area

Cubist Reports Daptomycin As Safe As Comparable Drugs

Mack Wants Human Face Put On Complex Biotech Research

Pre-Ischemic Pain May Reduce Cardiac Attacks By Tolerizing Myocardium To Oxygen Deficit

Phase III Of Chiron's Regranex Stopped For Lack Of Efficacy

NPS, Allelix Plan Merger So They Can Keep Independence